Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets

Daniel Neureiter; Sebastian Stintzing; Tobias Kiesslich; Matthias Ocker

doi:10.3748/wjg.v25.i25.3136

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets

Daniel Neureiter (Erstautor/-in)
, Sebastian Stintzing
, Tobias Kiesslich (Co-Autor/-in)
, Matthias Ocker

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

55 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	3136-3150
Fachzeitschrift	WORLD JOURNAL OF GASTROENTEROLOGY
Jahrgang	25
Ausgabenummer	25
DOIs	https://doi.org/10.3748/wjg.v25.i25.3136
Publikationsstatus	Veröffentlicht - 2019

Zugriff auf Dokument

10.3748/wjg.v25.i25.3136

Dieses zitieren

@article{50f5f0262cbc40f795ff5113e3a72771,

title = "Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets",

keywords = "DEACETYLASE INHIBITOR PANOBINOSTAT, DEATH LIGAND 1, PORTAL-VEIN, PHASE-III, SORAFENIB TREATMENT, FATTY LIVER, T-CELLS, C-MET, NONALCOHOLIC STEATOHEPATITIS, RADIOFREQUENCY ABLATION",

author = "Daniel Neureiter and Sebastian Stintzing and Tobias Kiesslich and Matthias Ocker",

note = "Neureiter: Paracelsus Med Univ, Salzburger Landeskliniken SALK, Canc Cluster Salzburg, Inst Pathol, A-5020 Salzburg, Austria; Kiesslich: Paracelsus Med Univ, Salzburger Landeskliniken SALK, Dept Internal Med 1, A-5020 Salzburg, Austria; Paracelsus Med Univ, Inst Physiol *** Pathophysiol, A-5020 Salzburg, Austria; ",

year = "2019",

doi = "10.3748/wjg.v25.i25.3136",

language = "English",

volume = "25",

pages = "3136--3150",

journal = "WORLD JOURNAL OF GASTROENTEROLOGY",

issn = "1007-9327",

publisher = "W J G PRESS",

number = "25",

}

TY - JOUR

T1 - Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets

AU - Neureiter, Daniel

AU - Stintzing, Sebastian

AU - Kiesslich, Tobias

AU - Ocker, Matthias

N1 - Neureiter: Paracelsus Med Univ, Salzburger Landeskliniken SALK, Canc Cluster Salzburg, Inst Pathol, A-5020 Salzburg, Austria; Kiesslich: Paracelsus Med Univ, Salzburger Landeskliniken SALK, Dept Internal Med 1, A-5020 Salzburg, Austria; Paracelsus Med Univ, Inst Physiol *** Pathophysiol, A-5020 Salzburg, Austria;

PY - 2019

Y1 - 2019

KW - DEACETYLASE INHIBITOR PANOBINOSTAT

KW - DEATH LIGAND 1

KW - PORTAL-VEIN

KW - PHASE-III

KW - SORAFENIB TREATMENT

KW - FATTY LIVER

KW - T-CELLS

KW - C-MET

KW - NONALCOHOLIC STEATOHEPATITIS

KW - RADIOFREQUENCY ABLATION

U2 - 10.3748/wjg.v25.i25.3136

DO - 10.3748/wjg.v25.i25.3136

M3 - Review article

C2 - 31333307

SN - 1007-9327

VL - 25

SP - 3136

EP - 3150

JO - WORLD JOURNAL OF GASTROENTEROLOGY

JF - WORLD JOURNAL OF GASTROENTEROLOGY

IS - 25

ER -